A Possible Guide as a Tool to Complementary Effects of New Coronavirus
(ندگان)پدیدآور
Afsaneh SadremomtazJavad HashemiAdeleh SahebnasaghSeyed Mohammad NabaviZayana M.Al-DahmaniShayesteh GheibiBita ShahramiReza MosaedPeyman ArfaSoheil RoshanzamiriMojtaba Mojtahedzadehنوع مدرک
Textزبان مدرک
Englishکلید واژگان
Sars-CoV-2Drugs
adjuvant therapies
شماره نشریه
4سازمان پدید آورنده
XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, NetherlandsDepartment of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Clinical Research Center, Department of Internal Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Biochemistry Department, College of Medicine, Sultan Qaboos University, Alkhoud, Oman.
Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran
Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran
Department of Anesthesiology and Intensive Care, School of Medicine, Aja University of Medical Sciences, Tehran, Iran.
Burn Intensive Care Unit, Shahid Motahari Burn Hospital, Iran University of Medical Sciences, Tehran, Iran
Burn Intensive Care Unit, Shahid Motahari Burn Hospital, Iran University of Medical Sciences, Tehran, Iran
Department of Clinical Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran




